Evidence map›Paper›PMID 39459597›Full record

ArticleLife (Basel, Switzerland)2024

Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients.

Edwin Korouri, Charlotte Jeong, Hannah Peterson, Fernando Valenzuela, Ricardo Romiti, Johannes A Didaskalu, Alexander Egeberg, Hazel H Oon, Lara Valeska Maul, Paige Kingston and 7 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07634016 (Global Healthcare Study on Psoriasis), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07634016 recruitingnot on this mapstarted 2025, after this paper: background citation

Global Healthcare Study on Psoriasis

Typeobservational_patient_registrySponsorJulia Tatjana MaulRan2025 to 2029Enrolled9,600ConditionsPsoriasis (PsO)
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Edwin KorouriChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Charlotte JeongCollege of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Hannah PetersonDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Fernando ValenzuelaDepartment of Dermatology, University of Chile, Santiago 8330111, Chile.ORCID 0000-0003-1032-9347
Ricardo RomitiDepartment of Dermatology, School of Medicine, University of São Paulo, São Paulo 05508-220, Brazil.
Johannes A DidaskaluFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Alexander EgebergDepartment of Dermatology, Bispebjerg Hospital, 2400 Copenhagen, Denmark.
Hazel H OonNational Skin Centre, Singapore 308205, Singapore.ORCID 0000-0001-7607-3124
Lara Valeska MaulFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Paige KingstonDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Kathryn LeeDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Margaret Y HuangDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Danielle YeeDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Kevin ArtigaDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0002-0089-959X
Rosario AgueroDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90007, USA.
Julia-Tatjana MaulFaculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-9914-1545
April W ArmstrongDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The purpose of this study is to compare the rate of COVID-19 vaccination among psoriasis patients internationally and to correlate it with their treatment regimens. (2) Methods: We conducted a cross-sectional study from January 2021 to October 2022 among adults in the United States (US), Chile, China, Switzerland, and Singapore using the Global Healthcare Study on Psoriasis survey. (3) Results: A total of 310 psoriasis patients in the US (98), Chile (32), China (80), Switzerland (39), and Singapore (61) were surveyed. Of these, 248 patients (80.0%) were vaccinated at least once for COVID-19 (Chile: 100%, Singapore: 100%, US: 93.9%, Switzerland: 69.2%, China: 45.0%). Compared with other countries, patients in China were 89% less likely to report at least one COVID-19 vaccination (1 - 0.11 = 0.89; OR 0.11; 95% CI: 0.03-0.48), and patients in Switzerland were 80% less likely (1 - 0.20 = 0.80; OR 0.20; 95% CI: 0.05-0.79). Compared with patients on biologics, patients on topicals were 10.9 (95% CI: 2.1-56.6) times more likely to report at least one COVID-19 vaccination, and patients on oral systemics were 7.2 times more likely (95% CI: 1.6-31.6). (4) Conclusions: Country of residence and treatment regimen are associated with different COVID-19 vaccination rates in psoriasis patients.

Indexed as

biologicsCOVID-19globalpsoriasisvaccination

Identifiers

PMID39459597
PMCPMC11509075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.